Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultrahypofractionated Versus Normofractionated Sequential Boost After Whole-breast Radiation Therapy in Patients Treated With Breast-conserving Surgery for Breast Cancer

NCT07590505 is registered in ClinicalTrials.gov with Cancer Research Antwerp as lead sponsor.

NCT NCT07590505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07590505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultrahypofractionated Versus Normofractionated Sequential Boost After Whole-breast Radiation Therapy in Patients Treated With Breast-conserving Surgery for Breast Cancer
Lead sponsor
Cancer Research Antwerp
Phase
Phase 3
Overall status
Completed
Start date
March 29, 2022
Completion date
March 25, 2026
Enrollment
132 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer